Amwell announces new chief financial officer
Amwell (NYSE: AMWL), a digital care leader, has announced Mark Hirschhorn as its new Chief Financial Officer (CFO), effective October 21. Hirschhorn, with over 30 years of experience in healthcare technology, will oversee Amwell's financial operations, optimization, and capital allocation activities. He succeeds Robert Shepardson, who has held the position since 2021.
Hirschhorn's appointment marks a shift for Amwell as it moves from intense R&D investment to an operational focus on efficiency, cash flow optimization, and profitable growth. His experience includes roles as CEO at TapestryHealth and CFO/COO positions at Teladoc Health and Talkspace. Amwell's CEO, Dr. Ido Schoenberg, expressed confidence in Hirschhorn's ability to lead the company for the benefit of all stakeholders.
Amwell (NYSE: AMWL), un leader nel digitale nel settore della cura, ha annunciato Mark Hirschhorn come nuovo Chief Financial Officer (CFO), con effetto dal 21 ottobre. Hirschhorn, con oltre 30 anni di esperienza nella tecnologia sanitaria, supervisionerà le operazioni finanziarie di Amwell, l'ottimizzazione e le attività di allocazione del capitale. Sostituisce Robert Shepardson, che ha ricoperto la posizione dal 2021.
L'appuntamento di Hirschhorn segna un cambiamento per Amwell mentre si sposta da un'intensa investimento in R&D a un focus operativo sull'efficienza, sull'ottimizzazione del flusso di cassa e sulla crescita profittevole. La sua esperienza include ruoli come CEO di TapestryHealth e posizioni di CFO/COO presso Teladoc Health e Talkspace. Il CEO di Amwell, Dr. Ido Schoenberg, ha espresso fiducia nella capacità di Hirschhorn di guidare l'azienda a beneficio di tutti gli stakeholder.
Amwell (NYSE: AMWL), un líder en atención digital, ha anunciado a Mark Hirschhorn como su nuevo Chief Financial Officer (CFO), con efecto a partir del 21 de octubre. Hirschhorn, con más de 30 años de experiencia en tecnología sanitaria, supervisará las operaciones financieras de Amwell, la optimización y las actividades de asignación de capital. Sucede a Robert Shepardson, quien ha ocupado el puesto desde 2021.
El nombramiento de Hirschhorn marca un cambio para Amwell a medida que pasa de una intensa inversión en I+D a un enfoque operativo en la eficiencia, la optimización del flujo de caja y el crecimiento rentable. Su experiencia incluye roles como CEO en TapestryHealth y posiciones de CFO/COO en Teladoc Health y Talkspace. El CEO de Amwell, Dr. Ido Schoenberg, expresó confianza en la capacidad de Hirschhorn para liderar la empresa en beneficio de todos los interesados.
Amwell (NYSE: AMWL), 디지털 의료 분야의 선두주자인 Amwell이 Mark Hirschhorn을 새로운 최고재무책임자(CFO)로 발표했습니다. 그의 임기는 10월 21일부터 시작됩니다. Hirschhorn은 의료 기술 분야에서 30년 이상의 경력을 가지고 있으며, Amwell의 재무 운영, 최적화 및 자본 배분 활동을 감독할 것입니다. 그는 2021년부터 이 직위를 맡아온 Robert Shepardson을 대신하게 됩니다.
Hirschhorn의 임명은 Amwell이 대규모 R&D 투자에서 운영 효율성, 현금 흐름 최적화 및 수익성 있는 성장으로 초점을 전환함에 따라 전환점을 나타냅니다. 그의 경력에는 TapestryHealth의 CEO 직책과 Teladoc Health 및 Talkspace의 CFO/COO 직책이 포함됩니다. Amwell의 CEO인 Dr. Ido Schoenberg은 Hirschhorn이 모든 이해관계자에게 이익이 되는 방향으로 회사를 이끌 것이라는 확신을 표현했습니다.
Amwell (NYSE: AMWL), un leader dans le domaine des soins numériques, a annoncé Mark Hirschhorn comme son nouveau directeur financier (CFO), à compter du 21 octobre. Hirschhorn, fort de plus de 30 ans d'expérience dans la technologie de la santé, supervisera les opérations financières d'Amwell, l'optimisation et les activités d'allocation de capital. Il succède à Robert Shepardson, qui a occupé ce poste depuis 2021.
La nomination de Hirschhorn marque un tournant pour Amwell, qui passe d'un investissement intensif en R&D à un focus opérationnel sur l'efficacité, l'optimisation des flux de trésorerie et la croissance rentable. Son expérience inclut des rôles en tant que PDG de TapestryHealth et des postes de CFO/COO chez Teladoc Health et Talkspace. Le PDG d'Amwell, Dr. Ido Schoenberg, a exprimé sa confiance dans la capacité de Hirschhorn à diriger l'entreprise au bénéfice de toutes les parties prenantes.
Amwell (NYSE: AMWL), ein führendes Unternehmen im digitalen Gesundheitswesen, hat Mark Hirschhorn als neuen Chief Financial Officer (CFO) bekannt gegeben, der am 21. Oktober beginnt. Hirschhorn, der über 30 Jahre Erfahrung in der Gesundheitstechnologie verfügt, wird die finanziellen Abläufe, die Optimierung und die Kapitalzuweisungsaktivitäten von Amwell überwachen. Er tritt die Nachfolge von Robert Shepardson an, der die Position seit 2021 inne hatte.
Die Ernennung von Hirschhorn markiert einen Wechsel für Amwell, da das Unternehmen von intensiven F&E-Investitionen zu einem operationellen Fokus auf Effizienz, Cashflow-Optimierung und profitables Wachstum übergeht. Zu seiner Erfahrung gehören Positionen als CEO bei TapestryHealth sowie CFO/COO bei Teladoc Health und Talkspace. Der CEO von Amwell, Dr. Ido Schoenberg, äußerte Vertrauen in Hirschhorns Fähigkeit, das Unternehmen zum Wohle aller Stakeholder zu führen.
- Appointment of experienced CFO Mark Hirschhorn with over 30 years in healthcare technology
- Strategic shift towards operational efficiency and profitable growth
- Focus on optimizing cash flow and enhancing shareholder value
- None.
Industry veteran Mark Hirschhorn joins Amwell leadership team
BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, today announced Mark Hirschhorn will become Amwell Chief Financial Officer (CFO) effective Oct. 21, succeeding Robert “Bob” Shepardson, who has been in the role since 2021. Hirschhorn will oversee Amwell’s financial operations, enterprisewide optimization and capital allocation activities, and will play a meaningful leadership role in guiding the company’s strategy to support its long-term growth objectives and enhance shareholder value.
Hirschhorn is a healthcare technology industry leader, with over three decades of experience in financial and strategic operations, having served in senior executive positions across both public and private companies. Most recently, he served as chief executive officer (CEO) of TapestryHealth where he significantly scaled the company’s revenue and profitability. Prior to that, he spent seven years at Teladoc Health where he held key roles as CFO and chief operating officer (COO), and Talkspace where he contributed to strong growth and strategic repositioning efforts as president and COO.
“Mark’s experience blends keen financial acumen and seasoned leadership, encompassing corporate finance, operations, strategy, capital allocation and M&A,” said Ido Schoenberg, M.D., chairman and CEO of Amwell. “This change represents an evolution for our company as we move beyond a period of intense R&D investment to an operational focus aimed at achieving greater efficiencies, optimizing cash flow and delivering profitable growth while maintaining our dedication to enabling our clients’ aspirations. Mark makes a great addition to our executive team and is dedicated to leading the company for the benefit of all stakeholders – clients, shareholders and team members.”
“I am excited to join the talented team at Amwell as we continue on our path to profitability. Amwell is a great company on a meaningful mission, to empower healthcare organizations to derive the many benefits of digitally enabled healthcare. I am aligned with Amwell’s leadership team on many philosophies, principles and strategies to build the business and enhance shareholder value,” Hirschhorn said.
Schoenberg added, “All of us at Amwell thank Bob Shepardson for his contributions as CFO. Bob has been a great leader as we navigated past our IPO and beyond our period of re-platforming and worked to align our overall cost structure, setting Amwell up for profitable growth.”
About Amwell
Amwell is a leading hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. We offer a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the digital care of more than 50 health plans, which collectively represent more than 100 million covered lives, and many of the nation’s largest health systems. For more information, please visit https://business.amwell.com/.
©2024 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, Amwell ConvergeTM, CarepointTM and the Amwell Logo are registered trademarks or trademarks of American Well Corporation.
Notice of Ownership
All materials contained herein are the property of American Well Corporation and are copyrighted under United States law and applicable international copyright laws and treaty provisions. The materials contained herein are not work product or "work for hire" on behalf of any third party. The materials contained herein constitute the confidential information of American Well Corporation, except for specific data elements provided by third parties, which are the confidential information of such third parties. The content contained herein results from the application of American Well proprietary processes, analytical frameworks, algorithms, business methods, solution construction aids and templates, all of which are and remain the property of American Well Corporation.
Trademark Notice
All of the trademarks, service marks and logos displayed on these materials (the "Trademark(s)") are registered and unregistered trademarks of American Well Corporation or third parties who have licensed their Trademarks to American Well Corporation. Except as expressly stated in these terms and conditions, you may not reproduce, display or otherwise use any Trademark without first obtaining American Well Corporation's written permission.
FAQ
Who is the new CFO of Amwell (AMWL)?
What is Mark Hirschhorn's background before joining Amwell (AMWL)?
What strategic shift is Amwell (AMWL) making with this new CFO appointment?
When will Mark Hirschhorn start as CFO of Amwell (AMWL)?
